Member Info for Oldapache

Ps,

It is looking more likely to be nas only as my broker has put up a corporate action for me to complete the “ nas “ forms before I can trade Accustem.

Vbw

Nightmarewalking / Cloudy,

It is not written in an rns that the bods have changed from listing on both exchanges to just nas, which is the reason Cloudy currently has the view and I believe it should have been as the last rns on the topic has led us to assume just listing on nas. Really bad comms either way.

Time will tell!

Vbw

FFF,
Might not be random, these boards are full to overflowing with " connections "

I've only been Investing since 2008 and I see the same " connections " moving onto a board then move off to another and repeat.

Pump and dump merchants, pure and simple.

ps, nightmare / harchris, not saying you by the way.

vbw

HarChris,

Good call, I split mine 3 ways a while back 1/3rd 4D, 1/3rd Ygen leaving 1/3rd Tils.

All out of profits from Tils.

vbw

oops, substitute did for did'nt.

Thought process changed part way through writing.

vbw

You can see why the bods did'nt want that other company, can't remember the name, to be listed over the pond!

vbw

Rhetorical question, why did the RNS not state the anticipated value of the market to Tils?

Booooooooooooom.

Kerching

vbw

JohnHenry,

Fully agree.

vbw

NM.

vbw

NM.

vbw

Denny11,

".........could lose out heavily "

Not even a subtle negative comment, so I'll say.................... could be far better off and win out heavily.

Just to keep the board from being overun by negative " bedwetters " eh.

Denny11,

Why did you feel the need to even comment?

As they say, if the cap fits!

This is a public board for all to say what they want, the " bedwetters " have done me a favour, so, just thanking them. lols.

There I said it, lols.

Small 365 share top up for me, now tucked away.

Carry on bedwetters, you have done me a great favour for my future financials.

vbw

I'm sure we will get another RNS which should leave no room for interpretation.

Sack the Nomad.

vbw

Rns 16/9/2020 together with circular for voting same date.

The bods have to adhere to the court and furthermore to the detail outlined in the circular which was the legal wording attributable to getting it voted through.

I can't see the bods not adhering to the court as they would be in contempt and leave themselves open to company and possibly individual prosecution.

vbw

As the Accustem D-merger was agreed in court I believe that the bods will have to follow the wording set out in the court case, therefore, list on LSE and NAS.

Anyone got the court case wording which I assume was RNS'd.

I need to flit back through the Rns's now as only just seen this one.

vbw

Lols.

vbw

Thats clever, de-merge it, then buy it back bit by bit!!!!

Jab102,

Tils is partnering with Provention Bio. I fink!

Can someone more knowledgeable please confirm if thats correct or what the actual cross reference with Tils refers to.

To re-state, FORALUMAB is the only fully human anti-CD3 monoclonal antibody in clinical development in the world.
To cover off:-
1.) Liver diseases.
2.) NASH.
3.) PBs.
4.) Colitis.
5.) MS.
6.) TID.
7.) IBD.
8.) Psoriasis.
9.) Rheumatoid Arthritis.

Are we talking multi billion $ products in multi billion $ markets?

You betcha.

vbw

FC,

See RNS 20/10/ 2020, all in there.

vbw